# Trade Mark Journal No.2026/011 13 March 2026

## UK00004344909 24 February 2026 (5,42,44)

SOFE-M

Class 5
  Anti-cancer preparations; Anti-cancer drugs; Compounds for treating cancer; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Diagnostic testing materials for medical use; Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations; Chemical preparations for pharmaceutical purposes; Biological preparations for medical purposes; Drugs for medical purposes; Biochemical preparations for medical use; Medicines for human purposes.
Class 42
  Scientific research for medical purposes in the area of oncology; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Testing of pharmaceuticals; Pharmaceutical research and development; Pharmaceutical drug development services; Research relating to pharmaceuticals; Conducting clinical trials for pharmaceutical products; Providing scientific research information in the field of pharmaceuticals; Research and development of pharmaceutical preparations for treating cancer; Providing information about the results of clinical trials for pharmaceutical products; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Biological research, clinical research and medical research; Medical research in the field of oncology; Provision of information and data relating to medical research and development; Clinical trials; medical research; Biomedical research services; Biotechnology research.
Class 44
  Cancer screening services; Medical analysis services for diagnosis and treatment of cancer; Medical services for the treatment of cancer; Pharmaceutical consultation; Pharmaceutical services; Advisory services relating to pharmaceuticals; Consultancy and information services relating to pharmaceutical products; Consultancy and information services provided via the Internet relating to pharmaceutical products; Medical testing; Medical testing for diagnostic and treatment purposes; Medical testing services relating to the diagnosis and treatment of cancer; Medical information services in the field of oncology; Providing on-line information relating to oncology; medical analysis services for diagnostic and treatment purposes; medical screening; Genetic testing for medical purposes.

Eli Lilly and Company

Representative: Page, White & Farrer Limited